Mar 24, 2025 · Exenatide is an injectable diabetes medicine that helps control blood sugar levels. This medication helps your pancreas produce insulin more efficiently. Byetta is a short-acting form of exenatide.

Exenatide is a glucagon-like peptide-1 receptor agonist (GLP-1 receptor agonist) also known as incretin mimetics. [7] It works by increasing insulin release from the pancreas and decreases excessive glucagon release. [7] Exenatide was approved for medical use in …

Apr 1, 2025 · Exenatide injection is used together with diet and exercise to treat type 2 diabetes. This medicine is available only with your doctor's prescription.

May 29, 2023 · Exenatide is a GLP-1 receptor agonist released from the gut and acts to increase glucose-dependent insulin secretion from pancreatic beta cells, suppress glucagon secretion, delay gastric emptying, and reduce food intake. The binding of the drug to pancreatic GLP-1 receptors mediates these actions.

Dec 27, 2024 · Exenatide (Byetta) is commonly used to help lower blood sugar levels in people with type 2 diabetes. Exenatide may also be used for other conditions as determined by your healthcare provider.

Exenatide is an injectable drug that reduces the level of sugar (glucose) in the blood. It is used for treating type 2 diabetes. Exenatide belongs in a class of drugs called incretin mimetics because these drugs mimic the effects of incretins.

Oct 19, 2022 · Exenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist. It acts like GLP-1, a hormone that tells your body to release insulin after you eat. Also like GLP-1, exenatide blocks your liver from releasing sugar into your blood. These actions help control and maintain blood sugar levels in people with type 2 diabetes. Drug Facts

Aug 7, 2023 · Detailed Exenatide dosage information for adults and children. Includes dosages for Diabetes Type 2; plus renal, liver and dialysis adjustments.

Exenatide ER is the first medication for the treatment of T2DM dosed on a weekly schedule. Exenatide ER is a glucagon-like peptide-1 (GLP-1) receptor agonist, the third to be approved in the US, and is associated with a low risk of hypoglycemia, may result in weight loss, and has proven to be a safe and effective treatment for T2DM.

Sep 26, 2023 · Exenatide is given as an injection just under the surface of the skin. It is administered using a syringe and needle or by using an injection device called a pre-filled pen. It is used in addition to other antidiabetic medicines. …